CONVERTIBLE NOTE DUE SEPTEMBER 13, 2019Convertible Security Agreement • September 27th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • New York
THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of Creative Medical Technology Holdings, Inc., a Nevada corporation, (the “Borrower”), due September 20, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
COMMON STOCK PURCHASE WARRANT Creative Medical Technology Holdings, Inc.Security Agreement • September 27th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Global Capital Partners Group, LLC or its registered assigns (the “Holder”), with an address at: 1361 East 10th Street, Brooklyn, NY 11730, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), up to 1,247,618 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 13, 2018, between Creative Medical Technology Holdings, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
